Sign in
Active, not recruitingNo phase

Etiopathogenesis of Anemia in Chronic Liver Disease

Key facts

Who runs it
Post Graduate Institute of Medical Education and Research, Chandigarh
Where
India1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
125 people, planned
Started
1 Sept 2020
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
13 November 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Age 18-75 years
  • Either gender
  • Patients with chronic liver disease with anemia (Hemoglobin in Non-pregnant women (18 years of age and above) <12g/dl and in men <13g/dl

Who cannot take part

  • Post liver transplant patients
  • Patients who are on psychoactive drugs, like sedatives or antidepressants
  • HIV infection
  • Patients with ongoing active bleeding
  • Patients with known primary hematological disorders
  • Renal dysfunction (S. Creatinine ≥ 2mg/dL)
  • Those who do not consent to participate in the study
  • Pregnancy/Lactation
  • Patients with uncontrolled sepsis
  • Patients who are too sick to carry out the protocol

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Anemia is the most common complication of liver cirrhosis and is seen in 75% of cases. The etiology of anemia in liver disease is diverse and often multi-factorial. Given the diverse and sometimes multifactorial etiology of cirrhosis, it is difficult to determine the exact cause of anemia in these groups of patients. The most common type of anemia encountered in liver cirrhosis is normocytic normochromic anemia, attributable to the chronic inflammatory state. The key question in management of anemia in patients with liver disease which specific factor needs to be corrected to restore hemoglobin levels and improve overall clinical status and improve severity scores.

The group in the trial

  • Chronic liver disease with anemia

    All patients with anemia as diagnosed by WHO criteria in patients with liver disease of any etiology.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Role of Iron Metabolism, Nutritional Deficiency, Gastrointestinal Loss, and Chronic Inflammation in the Etiopathogenesis of Anemia in Chronic Liver Disease
Record updated
13 November 2026